Harmony Biosciences
HRMY
HRMY
221 hedge funds and large institutions have $1.58B invested in Harmony Biosciences in 2023 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 62 increasing their positions, 77 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
+17
Holders Change %
+8.33%
% of All Funds
3.24%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
55
Increased
62
Reduced
77
Closed
35
Calls
$5.6M
Puts
$1.78M
Net Calls
+$3.82M
Net Calls Change
-$1.33M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$45.8M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$39.6M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$24.2M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16.2M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$7.35M |
